About this Research Topic
“A year in review: Discussions in Vaccines and Molecular Therapeutics” is part of a wider series of Research Topics across Frontiers in Immunology, hosted by our Speciality Chief Editors.
This Research Topic aims to spark discussion around popular spontaneous articles from 2021 in Vaccines and Molecular Therapeutics. The Vaccines and Molecular Therapeutics field is continuously evolving, therefore we are seeking to understand developments and perspectives on articles that have attracted attention throughout the year.
—---
The chosen manuscripts are :
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective?
Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
Review: Vaccine Myth-Buster – Cleaning Up With Prejudices and Dangerous Misinformation
—-----
This topic will be summarized by the specialty chief editors in an editorial alongside their vision for Vaccines and Molecular Therapeutics.
We welcome Opinions, Perspectives, Hypotheses and Theory, and Mini-Review article types to facilitate this discussion. Please note only papers that are relevant and add a significant contribution to the discussion articles will be considered.
This Research Topic aims to spark discussion around popular spontaneous articles from 2021 in Vaccines and Molecular Therapeutics. The Vaccines and Molecular Therapeutics field is continuously evolving, therefore we are seeking to understand developments and perspectives on articles that have attracted attention throughout the year.
—---
The chosen manuscripts are :
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective?
Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
Review: Vaccine Myth-Buster – Cleaning Up With Prejudices and Dangerous Misinformation
—-----
This topic will be summarized by the specialty chief editors in an editorial alongside their vision for Vaccines and Molecular Therapeutics.
We welcome Opinions, Perspectives, Hypotheses and Theory, and Mini-Review article types to facilitate this discussion. Please note only papers that are relevant and add a significant contribution to the discussion articles will be considered.
Keywords: Discussions in Vaccines and Molecular Therapeutics
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
